Consolidated Planning Corp’s Labcorp LH Stock Holding History

Consolidated Planning Corp’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-108	Closed	-$26K	–	276
2021 Q3	$26K	Buy	+108	New	+$27.2K	0.02%	225

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

MCM

Melvin Capital Management New York $9.86B AUM 16.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Consolidated Planning Corp's LH Position: Q4 2021 in Review

Consolidated Planning Corp sold out of Labcorp (LH) in Q4 2021, closing a stake of 108 shares — an estimated $26K sold.

Consolidated Planning Corp first reported a position in LH in Q3 2021 and held it in 1 quarter. The position peaked at $26K in Q3 2021. 1,061 funds tracked by Wall St. Rank hold LH as of Q4 2021.

Consolidated Planning Corp reported no remaining Labcorp position as of Q4 2021 after selling out during the quarter.
Consolidated Planning Corp sold 108 Labcorp shares in Q4 2021, an estimated $26K.
Consolidated Planning Corp first reported a position in Labcorp in Q3 2021 and held it in 1 quarter.
Consolidated Planning Corp's Labcorp position peaked at $26K in Q3 2021.
1,061 funds tracked by Wall St. Rank held Labcorp as of Q4 2021.

Based on Consolidated Planning Corp's 13F filing for Q4 2021, filed 11 Feb 2022.